Journal article
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
Abstract
BACKGROUND: Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe.
OBJECTIVES: The aim of this review is to assess the risk of fatal and non-fatal serious adverse events in trials that randomised patients with chronic asthma to regular salmeterol with …
Authors
Cates CJ; Lasserson TJ; Jaeschke R
Journal
, , No. 3,
Publisher
Wiley
DOI
10.1002/14651858.cd006922.pub2
ISSN
1465-1858